Bullish Two Hundred Day Moving Average Cross - EJUL
Looking at the chart above, EJUL's low point in its 52 week range is $27.3609 per share, with $31.25 as the 52 week high point — that compares with a last trade of $30.45.
Read more →Trading Venues
Noteworthy Tuesday Option Activity: GM, BA, CVS
Boeing Co. (Symbol: BA) options are showing a volume of 30,237 contracts thus far today. That number of contracts represents approximately 3.0 million underlying shares, working out to a sizeable 58.8% of BA's average d…
Read more →Arabica Coffee Advances as Brazil Rains Threaten to Delay the Coffee Harvest
September arabica coffee (KCU26) today is up +2.15 (+0.66%), and September ICE robusta coffee (RMU26) is down -45 (-1.16%).
Read more →Stocks Gain as Chipmakers Rebound
The S&P 500 Index ($SPX) (SPY) today is up +0.38%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.17%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.26%. September E-mini S&P futures (ESU26) are up +0.35%, an…
Read more →Corn Starts the Week with Strength
Corn futures closed the Monday session slipping back from the highs, rounding out trade with 2 to 5 ½ cent gains. The CmdtyView national average Cash Corn price was up a nickel at $4.18 ¾.
Read more →Palantir Stock Is Down More Than 35% from Its Peak. Is It Finally a Buy?
Just a few months ago, investors couldn't get enough of Palantir Technologies (NASDAQ: PLTR). The company -- known for "big data" analytics -- was delivering record earnings, demand for its artificial intelligence (AI) …
Read more →Why Equifax Stock Is Tumbling Today
With much of this concern already priced in, there’s a case to be made that today’s dip is a buying opportunity for volatility-tolerant investors.
Read more →SpaceX: The Artificial Intelligence (AI) Infrastructure Build-out Just Got Interesting (NASDAQ:SPCX)
Over the last month, SpaceX has signed compute capacity deals worth tens of billions of dollars.
Read more →Crude Oil Prices Rally on Global Supply Risks
August WTI crude oil (CLQ26) today is up +1.75 (+2.10%), and August RBOB gasoline (RBQ26) is up +0.0017 (+0.05%).
Read more →Agios Ends Tebapivat Development For Sickle Cell Disease After Phase 2 Trial; Stock Down
(RTTNews) - Agios Pharmaceuticals Inc. (AGIO) a commercial-stage biopharmaceutical company, on Tuesday announced the discontinuation of the Phase 2 trial evaluating Tebapivat for Sickle Cell Disease, as the drug failed …
Read more →Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics, Stock Down
(RTTNews) - Akari Therapeutics, Plc (AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced a strategic research collaboration wit…
Read more →AGD Ex-Dividend Reminder - 7/23/26
In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from AGD is likely to continue, and whether the current estimated yield of 11.88% o…
Read more →Ex-Div Reminder for MFS Intermediate Income Fund (MIN)
In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from MIN is likely to continue, and whether the current estimated yield of 9.66% on…
Read more →FMN Ex-Dividend Reminder - 7/23/26
In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from FMN is likely to continue, and whether the current estimated yield of 4.73% on…
Read more →CVS Health To Sell Pet Medications At Its Pharmacies
(RTTNews) - On Tuesday, CVS Health Corp. (CVS) announced avilability of common prescription medications for dogs and cats at its approximately 9000 pharmacy locations across the US.
Read more →Accruent Collaborates With PowerX For AI-Powered Infrastructure Solutions
(RTTNews) - Accruent, an operating company of Fortive Corporation (FTV), Tuesday announced a new partnership with PowerX, a telecom infrastructure intelligence company, to integrate the latter's AI-driven energy intelli…
Read more →Stocks Pressured as Middle East Hostilities Boost Inflation Risks
The S&P 500 Index ($SPX) (SPY) on Monday closed down -0.19%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.59%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.04%. September E-mini S&P futures (ESU2…
Read more →After Its Earnings Scare, Is IBM's Dividend Still Safe?
Last week was a rough one for International Business Machines (NYSE: IBM) as the company's preannounced results rattled the stock, and that's putting it lightly. Shares cratered, and fears mounted about the business's f…
Read more →Mueller Industries Profit Climbs In Q2
(RTTNews) - Mueller Industries (MLI) announced earnings for its second quarter that Increased, from the same period last year
Read more →Vicor Corp Reports Rise In Q2 Profit
(RTTNews) - Vicor Corp (VICR) revealed earnings for its second quarter that Increased, from last year
Read more →Hasbro Swings To Profit In Q2; Boosts FY26 Revenue Growth Outlook; Declares Dividend
(RTTNews) - Toy and game company Hasbro, Inc. (HAS) reported Tuesday net earnings attributable to Hasbro for the second quarter of $160.9 million or $1.12 per share, compared to a net loss of $855.8 million or $6.10 per…
Read more →Northrop Grumman Raises FY26 MTM-adj. EPS Guidance By $1.20
(RTTNews) - Northrop Grumman (NOC) increased its sales and EPS guidance for the year based on the demand for its technologies. For fiscal 2026, the company now expects: MTM-adjusted EPS in a range of $28.60 — $29.10, re…
Read more →Positron Gains Three Orders For PET/CT Units Facilitating Cardiovascular Diagnostics
(RTTNews) - Positron Corporation (POSC), a medical technology company, on Monday reported receiving three orders for the company's 64-slice PET/CT scan machines through multi-year agreements for use in cardiological dia…
Read more →Novartis Q2 Profit Drops 19% Despite Sales Growth; Reaffirms FY26 Outlook
(RTTNews) - Novartis AG (NVS) Tuesday reported a relatively lower second quarter income, despite generating a modest increase in net sales, driven by strong growth in its oncology portfolio. The Swiss drugmaker also rea…
Read more →